Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Celgene
M.D. Anderson Cancer Center
Medical College of Wisconsin
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Cedars-Sinai Medical Center
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Celyad Oncology SA
Eastern Cooperative Oncology Group
Northside Hospital, Inc.
Shanghai Pudong Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hackensack Meridian Health
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute